Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.
8-aminoquinolines• Drugs in this group have amino group at   position 8 of quinoline ring• Important members of this  fami...
• Such drugs have OCH3 group at position 6• This molecule has antimalarial  activity but when side chain  is introduced at...
• It contains tertiary amino group and when it is  converted into primary amino group the  compound is called primaquine, ...
• OCH3 is not necessary for antimalarial activity  but when replaced by OC2H5 the compound  became  – less active  – Toxic...
• Pentyl side chain gives maximum activity,  increase or decrease of chain result is reduction  of activity.• The branched...
Chemical synthesis (pamaquine)• Glycerol undergoes dehydration to produce  propene aldehyde• Dehydrating agent is sulphuri...
• Addition reaction of propene aldehyde and 4  methoxy 2-nitro aniline to form 4 methoxy 2-  nitro propene aldehyde
• Tautomerization: 4 methoxy 2-nitro propene  aldehyde (keto form) converted in enol form
• Enol form undergoes cyclization to form 8 nitro 6  methoxy dihydroquinoline which then oxidized to  form 8 nitro 6 metho...
• 6 methoxy 8 nitro quinoline undergoes  reduction to form 8 amino 6 methoxy  quinoline
• 8 amino 6 methoxy quinoline reacts with 2  chloro diethyl amino pentane to form  pamaquine
Therapeutic uses• Active against hepatic stage of plasmodium• Provide radical cure hepatic stage of P. vivax  and P. ovale...
Upcoming SlideShare
Loading in …5
×

8 aminoquinolines

5,913 views

Published on

Published in: Business, Technology
  • Be the first to comment

8 aminoquinolines

  1. 1. 8-aminoquinolines• Drugs in this group have amino group at position 8 of quinoline ring• Important members of this family include 1- Pamaquine 2- Primaquine, etc.
  2. 2. • Such drugs have OCH3 group at position 6• This molecule has antimalarial activity but when side chain is introduced at amino group antimalarial activity is intensified e.g pamaquine• It causes hemolysis of RBCs Diethyl amino pentyl side chain
  3. 3. • It contains tertiary amino group and when it is converted into primary amino group the compound is called primaquine, which is – Less toxic – Well tolerated – It is the most commonly used agent in this group in the treatment of malaria
  4. 4. • OCH3 is not necessary for antimalarial activity but when replaced by OC2H5 the compound became – less active – Toxic in nature• OCH3 when replaced by CH3 the compound become inactive• Introduction of halogens increases toxicity• Presence of quinoline ring is necessary for antimalarial activity. When pyridine ring is converted to piperidine (saturated) the compound became inactive
  5. 5. • Pentyl side chain gives maximum activity, increase or decrease of chain result is reduction of activity.• The branched side chain when converted into straight chain pentaquine is obtained• It has less antimalarial activity as compared to both pamaquine and primaquine
  6. 6. Chemical synthesis (pamaquine)• Glycerol undergoes dehydration to produce propene aldehyde• Dehydrating agent is sulphuric acid
  7. 7. • Addition reaction of propene aldehyde and 4 methoxy 2-nitro aniline to form 4 methoxy 2- nitro propene aldehyde
  8. 8. • Tautomerization: 4 methoxy 2-nitro propene aldehyde (keto form) converted in enol form
  9. 9. • Enol form undergoes cyclization to form 8 nitro 6 methoxy dihydroquinoline which then oxidized to form 8 nitro 6 methoxy quinoline
  10. 10. • 6 methoxy 8 nitro quinoline undergoes reduction to form 8 amino 6 methoxy quinoline
  11. 11. • 8 amino 6 methoxy quinoline reacts with 2 chloro diethyl amino pentane to form pamaquine
  12. 12. Therapeutic uses• Active against hepatic stage of plasmodium• Provide radical cure hepatic stage of P. vivax and P. ovale• It also acts at gametocytes, hence used as prophylactic drugs• Used in combination with chloroquine for complete eradication of malaria• Side effect: hemolysis in G6 phosphate dehydrogenase deficient people

×